GI Oncology
From the Journals
Postcolonoscopy cancer rates persist despite quality protocols
Colonoscopy quality measures fail to improve disease rates in population-based study.
News
FDA approves lutetium Lu 177 dotatate for GEP-NETs
This is the first approval of a radiopharmaceutical for gastroenteropancreatic neuroendocrine tumors.
Conference Coverage
Circulating tumor cell assay shows promise for colorectal cancer screening
The CTC assay had an accuracy of 87.9% in the entire cohort of 620 colonoscopy patients, which included 327 patients with colorectal cancer of all...
Conference Coverage
Study IDs predictors of nonmelanoma skin cancer in IBD
Male gender and white race rank among epidemiologic risk factors that predict which IBD patients go on to develop nonmelanoma skin cancer.
From the Journals
New multi-analyte blood test shows promise in screening for several common solid tumors
Newly developed CancerSEEK utilizes combined assays for genetic alterations and protein biomarkers and has the capacity to identify the presence...
From the Journals
Proinflammatory diet may increase colorectal cancer risk
Junk food could cause colorectal cancer.
From the Journals
S-1 regimen noninferior to other frontline mCRC options
Frontline treatment with the oral fluoropyrimidine S-1 combined with irinotecan and bevacizumab was noninferior to other common regimens.
From the Journals
Study: Test carcinoembryonic antigen in colon cancer after surgery
Researchers suggest that a recommended preoperative measurement actually provides more predictive value postoperatively.
From the Journals
Tc-325 effective for immediate GI tumor bleeding
This powder seems to be more predictably effective in providing initial hemostasis in upper GI tumor bleeding, compared with conventional methods...
News from the FDA/CDC
FDA approves first trastuzumab biosimilar
The Food and Drug Administration has approved trastuzumab-dkst (Ogivri) as a biosimilar to trastuzumab (Herceptin) for the treatment of patients...